Table 5 Comparison between the two groups before and after 1:1 propensity score matching

LAT/SEC, %

31(9.6)

57(36.1)

<0.001*

4(5.3)

13(17.3)

0.020*

CHA₂DS₂-VASc

0.025*

0.870

 M0F1

105(51.5)

114(41.2)

35(46.7)

34(45.3)

 M1F2

99(48.5)

163(58.8)

40(53.3)

41(50.6)

Paroxysmal AF, %

176(86.3)

146(52.7)

<0.001*

21(28.0)

21(28.0)

1.000

Age, years

54.50±9.95

58.51±7.54

<0.001*

54.50±9.95

58.51±7.54

0.840

BMI, kg/m²

24.66±2.74

25.58±3.17

0.001*

24.89±2.78

25.04±2.56

0.753

DBP, mmHg

79(72-86.75)

80(74-89.50)

0.044*

76(70-86)

79(73-88)

0.249

HR, bpm

73(65-82)

76(67-87)

0.019*

72(65-86)

74(67-84)

0.774

Heart failure, %

1(0.5)

9(3.2)

0.036*

1(1.3)

1(1.3)

1.000

Anticoagulants, %

51(25.0)

102(36.8)

0.006*

28(37.3)

22(29.3)

0.299

PLT, ×10⁹/L

200.20±60.48

189.13±53.38

0.034*

190.56±54.10

194.91±53.04

0.620

ALP, U/L

68(57-82)

72(59.50-87)

0.028*

72(59-88)

68(56-89)

0.665

γ-GT, U/L

19(14-30)

26(17-42)

<0.001*

18(14-31)

22(16-32)

0.116

Scr, umol/L

60.05±17.18

64.03±16.99

0.012*

63.23±17.51

64.56±15.86

0.626

TC, mmol/L

3.78(3.16-4.36)

3.61(3.04-4.13)

0.033*

3.74(3.23-4.15)

3.70(3.28-4.29)

0.703

TG, mmol/L

1.25(0.85-1.75)

1.06(0.82-1.49)

0.016*

1.14(0.86-1.60)

1.16(0.82-1.61)

0.901

LDL-c, mmol/L

2.28(1.73-2.77)

2.05(1.57-2.65)

0.021

2.31(1.81-2.61)

2.18(1.74-2.66)

0.991

PT, s

12.10(11.13-13.38)

13.05(11.60-14.48)

<0.001*

12.60(11.20-13.40)

12.50(11.30-14.00)

0.748

APTT, s

29.65(26.50-35.65)

31.25(27.10-37.10)

0.041*

30.50(26.40-36.40)

31.20(26.90-36.50)

0.913

NT-proBNP, pg/mL

101.45(43.36-247.85)

582.50(347.20-1064.00)

<0.001*

153.60(50.18-508.70)

388.50(180.50-627.80)

0.400

IVSA, mm

8.0(7.0-9.0)

8.0(7.0-9.0)

0.001*

8.0(7.0-9.0)

8.0(7.0-9.0)

0.954

MPAD, mm

21.0(20.0-23.0)

22.0(21.0-24.0)

<0.001*

21.0(20.0-23.0)

22.0(21.0-23.0)

0.271

LEVF, %

68.0(65.0-71.0)

64.0(59.0-69.0)

<0.001*

67.0(63.0-70.0)

66.0(63.0-70.0)

0.829